Expanding Access of HIV Prevention Injection to Include Adolescents: MU-JHU
Researchers from the collaborative effort between Mulago-based Makerere University and Johns Hopkins University (MU-JHU) have disclosed that the soon-to-be-approved long-acting Cabotegravir injection, designed to prevent HIV, is deemed safe for adolescents. The administration of this HIV-preventing drug involves initial injections four weeks apart, followed by subsequent injections every eight weeks. The drug is intended for…